XLY, CA05335P7039

Acumen sets CAD 5.00 target for Auxly Cannabis Group stock

Published on 10/18/2026 at 13:16 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Q2 revenue reached CAD 45.80 million, up 18.00 percent year over year. Auxly Cannabis Group stock has results scheduled for November 16, 2026.

Catalyst and operating figures

  • Acumen Capital began coverage with a CAD 5.00 target on October 2, 2026.
  • Second-quarter revenue reached CAD 45.80 million, up 18.00 percent year over year.
  • Auxly expects to publish its third-quarter 2026 results on November 16, 2026.
XLY, CA05335P7039, Illustration mit AI erstellt.

Auxly Cannabis Group (ISIN CA05335P7039) generated CAD 45.80 million in revenue in the second quarter of 2026, an 18.00 percent increase from the prior-year period, according to Investing.com. The latest analyst catalyst followed on October 2, 2026, when Acumen Capital began coverage with a CAD 5.00 price target, as reported by IT Boltwise.

Target puts growth under scrutiny

The target rests on a stronger operating picture in the second quarter. Investing.com reported adjusted EBITDA of CAD 14.30 million, up 24.00 percent year over year, while gross margin expanded from 52.00 percent to 55.00 percent.

That combination gives the analyst call a measurable foundation, but the earnings mix still matters. Reported net income was CAD 7.70 million in the second quarter, while Simply Wall St listed earnings per share of CAD 0.075, down from CAD 0.088 in the year-earlier quarter.

What does the target mean for margins?

The key question is whether revenue growth converts into repeatable cash generation. Auxly reported CAD 2.76 million in operating cash flow for the second quarter and CAD 38.81 million in cash at June 30, 2026, figures that place the CAD 5.00 target alongside a balance-sheet test rather than revenue growth alone.

Three dated company milestones

On July 22, 2026, Auxly announced a 14-for-1 share consolidation through its investor-relations page at Auxly Cannabis Group. On August 13, 2026, second-quarter revenue reached CAD 45.80 million, according to Investing.com. On October 2, 2026, Acumen Capital set its CAD 5.00 target, according to IT Boltwise.

Next reporting date

Auxly is scheduled to release its third-quarter 2026 results on November 16, 2026, according to Investing.com. The release should show whether the second-quarter revenue and margin gains continued into the next reporting period.

Market value and operating scale

Auxly is listed on the Toronto Stock Exchange under ticker XLY and operates as a Canadian consumer-packaged-goods company focused on cannabis products. Its market capitalization was CAD 350.0 million on October 16, 2026, with a 52-week range of CAD 1.54 to CAD 3.75. For investors, the next earnings release will connect the CAD 5.00 target with updated revenue, margins and cash flow.

The further course of trading is shown by the continuously updated real-time quote of Auxly Cannabis Group stock.

Auxly Cannabis Group stock facts

  • Company: Auxly Cannabis Group Inc.
  • ISIN: CA05335P7039
  • Ticker: XLY
  • Primary exchange: Toronto Stock Exchange
  • Market capitalization: CAD 350.0 million (as of October 16, 2026)
  • 52-week range: CAD 1.54-CAD 3.75 (as of October 16, 2026)
  • Sector / Industry: Consumer staples / Cannabis products

Market context: Market report S&P/TSX Composite.

More news and analyses on Auxly Cannabis Group stock

Disclaimer...
en | CA05335P7039 | XLY | boerse | 70353392 | bgmi